Foregut Leaks-Role of Microbiome
ConditionGastrointestinal Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBaylor Research Institute
About this trial
Aims
1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes
Eligibility criteria
Qualifiers
Patients with an esophageal or stomach leak
Over 18 years old
Disqualifiers
Patients determined by physician/surgeon as not able to tolerate biopsy
Under 18 years old
Trial design
Treatments tested in this trial
- Biopsy and fluid samples
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
1Baylor Scott & White Center for Advanced Surgery75246, DallasTexas, United States
Sponsors and collaborators
Baylor Research Institute
Lead sponsor
Source ClinicalTrials.gov